2 published reports across 1 sub-industry — how the market prices the sector, which comparables set the range, and what has actually transacted.
The deeper cut: the landscape, the valuation spread, the situations that follow from it and the precedent transaction record.
Sector ReportSep 15, 2026Health Care
A sector-wide look at how the market prices biotechnology on forward revenue, what separates premium names from discount names, and what recent M&A shows about buyer behavior. Built for owners, management teams, and acquirers weighing capital allocation and partnership decisions.
Biotechnology · 21 pages · Free to read
What moved, what companies announced and what changed in M&A, every two weeks.
Bi-Weekly UpdateSep 11, 2026Health Care
This bi-weekly update tracks biotechnology's public market movers, major clinical and regulatory catalysts, and M&A activity from August 28 to September 11, 2026, for investors, operators and advisors monitoring sector-specific price drivers and deal flow.
Biotechnology · 7 pages · Free to read
Company valuation reports run the same method against a single business, public or private.